Unique embryologic and immunologic aspects of the vulva contribute to the diagnostic and therapeutic challenges of managing vulvar problems. Individual variations in care of the genital region, defined by personal and societal “norms,” may at times exacerbate vulvar problems. Three dimensions are considered in the evaluation of a vulvar problem: 1) lesion type, 2) lesion location, and 3) associated systemic and laboratory findings. This review of vulvar disease highlights a number of common and problematic vulvar conditions. Treatment options for vulvar conditions are covered with an expanded discussion of newer immune response modifiers.
The review highlights diagnosis and management of common and problematic vulvar conditions.
From the Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, New York.
Address reprint requests to: David C. Foster, MD, MPH, University of Rochester, School of Medicine and Dentistry, Department of Obstetrics and Gynecology, 601 Elmwood Avenue, Box 668, Rochester, NY 14642; E‐mail: firstname.lastname@example.org.
We would like to thank the following individuals who, in addition to members of our Editorial Board, will serve as referees for this series: Dwight P. Cruikshank, MD, Ronald S. Gibbs, MD, Gary D. V. Hankins, MD, Philip B. Mead, MD, Kenneth L. Noller, MD, Catherine Y. Spong, MD, and Edward E. Wallach, MD.
Received January 28, 2002. Received in revised form April 3, 2002. Accepted April 18, 2002.